Forward Pharma (FWP) Bullish Stance Reiterated at Jefferies Following Initial Interference Documents
Tweet Send to a Friend
Jefferies analyst Thomas Wei reiterated a Buy rating and $40 price target on Forward Pharma (NASDAQ: FWP) after the initial ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
